Skip to main content
Wellcome Sanger Institute
Careers | Find us | Contact us
  • About
    • Our Vision
    • Impact
    • Careers
    • Study
    • Equality, Diversity and Inclusion
    • Leadership
    • Strategy and Funding
    • Influencing Policy
    • Research Policies
    • Branding and Logos
    • Admin Groups
    • Campus Connections
  • Science
    • Groups
    • Programmes
    • Collaborations
    • Tools
    • Data
    • Sanger Projects
    • COVID-19
    • Publications
    • Research Policies
    • Sanger Seminar Series
  • People
    • Leadership
    • Faculty
    • Associate Faculty
    • Honorary Faculty
    • International Fellows
    • Science Staff
    • Non-science Staff
    • Full A-Z
  • Innovation
    • Innovation at the Institute
    • For Industry
    • For Researchers
    • Case Studies
    • Our Spin-Outs
    • Sanger Technologies
  • News

We apply and explore genomic technologies at scale to advance understanding of biology and improve health

  • First spatial map of human limb development reveals unexpected growth processes and explains syndromes found at birth 

    Scientists reveal unprecedented insights into human limb development, including the many intricate processes that govern their formation.

    Find out more

  • Map of disease-causing mutations in neurodevelopmental disorders and cancer revealed

    Researchers now understand the functional impact of thousands of genetic changes within the DDX3X gene. This could lead to enhanced diagnosis and treatment of various neurodevelopmental disorders and cancers.

    Find out more

  • World’s largest genetic project opens the door to new era for treatments and cures: UK Biobank’s major milestone

    The Wellcome Sanger Institute sequenced its share of 500,000 whole human genomes, contributing to the world’s largest single set of sequencing data

    Find out more

  • Pocket-sized DNA sequencers track malaria drug resistance in near real-time

    A team of scientists working in Ghana have pioneered on-site genomic surveillance to track changes in the malaria parasite, achieving sampling to sequencing within 48 hours. This will guide local interventions and policy in near real-time.

    Find out more

  • Sanger's research leveraged by a new company, Quotient Therapeutics, to create transformative medicines

    Quotient’s Somatic Genomics platform reveals new approaches to treating disease based on the vast genetic variation present in the body’s trillions of cells

    Find out more

Sanger Prize 2024 is now open

The winner of the Sanger Institute Prize will be offered a three-month internship with a research group at the Wellcome Sanger Institute. Travel, living and research expenses are all covered by the award.

Wellcome Sanger Institute

Our 2022/2023 Highlights document

Our Highlights document showcases the key discoveries and future research interests of our Scientific Programmes. These include vital insights into human, parasite and microbe evolution, cellular growth and activity, and the processes that underlie mutation and tumour formation. In addition, our Tree of Life Programme explores the diversity of complex life. ...more

 

Latest News and Blogs

Professor Alain Chédotal and Raphaël Blain, Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France

6 Dec 2023

First spatial map of human limb development reveals unexpected growth processes and explains syndromes found at birth 

Scientists reveal unprecedented insights into human limb development, including the many intricate processes that govern their formation.

AdobeStock and Wellcome Sanger Institute

6 Dec 2023

Map of disease-causing mutations in neurodevelopmental disorders and cancer revealed

Researchers now understand the functional impact of thousands of genetic changes within the DDX3X gene. This could lead to enhanced diagnosis ...

5 Dec 2023

From micron to metre: crossing scales in the human body

Scientists progress towards mapping and modelling a complex, dynamic and ‘multiscale’ system: the human body.

Sanger Logo

Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244

  • About
  • Legal
  • Data sharing
  • Careers
  • Privacy
  • Equality, Diversity, Inclusion
  • Study
  • Modern Slavery Statement
ROSPA Gold
Athena Swan

Expand footer

Wellcome Sanger Institute, Genome Research Limited (reg no. 2742969) is a charity registered in England with number 1021457

2023 Wellcome Sanger Institute | All rights reserved